Atelerix Raises £750K to Enhance Preservation Technology
Breaking Boundaries in Biotech: Atelerix Secures £750K Funding to Revolutionize Preservation Technology
In an exciting turn for the biotech industry, Atelerix, a trailblazing company based in Newcastle, UK, has successfully raised £750K in funding. This impressive investment comes from notable backers including ACF Investors and the innovative o2h Ventures. With these funds in hand, Atelerix is poised to enhance its branding and sales efforts while accelerating the widespread adoption of its groundbreaking hypothermic preservation technology.
At the helm of this transformation is CEO Alastair Carrington, who leads a team dedicated to addressing the complexities of cryogenic shipping.
Atelerix offers a patented hydrogel encapsulation technology that not only extends the shelf life of fresh products but also ensures the optimal storage and transportation of cells at ambient temperatures between 4-25 degrees. The ability to maintain over 90% cell viability for up to 14 days at room temperature represents a significant leap forward, reducing shipping costs by an astounding 50-80% while eliminating the need for specialized cryogenic containers or hazardous dry ice.
This innovative ambient temperature shipping solution is a game changer for the drug and cell therapy development landscape. By simplifying logistics and significantly cutting costs, Atelerix empowers researchers and scientists to concentrate on what truly matters: advancing therapies and enhancing patient outcomes. For startup founders and investors alike, Atelerix is a shining example of how strategic funding and pioneering technology can reshape industries, creating new opportunities for investment and growth in the biotech arena.
Key Terms Explained
- Funding
- Funding represents the financial investment into a startup or company. It usually comes from investors, venture capitals, or loans and is typically used to support business growth, product development or operations.
- Hydrogel Encapsulation Technology
- In the context of this text, this refers to a specific technology developed by Atelerix that increases the shelf life of fresh products and preserves cells during transportation, eliminating the need for cryogenic containers.
- Cryogenic Shipping
- Cryogenic shipping refers to the process of shipping items at extremely low temperatures, typically used in biological and medical fields to preserve cells or biological materials.
Frequently Asked Questions
- How much funding has Atelerix successfully raised?-Atelerix has successfully raised £750K in funding.
- Which companies have invested in Atelerix?+
- What is the key technology that Atelerix offers?+
- What benefits does Atelerix's technology provide?+
- What impact does Atelerix's shipping solution have on the drug and cell therapy development landscape?+
They've invested in Atelerix
Get to know these Biotech investors
Click here for a full list of 6,528+ startup investors in the UK